Nick Queen

Nick Queen, PhD, is a Scientist II in Analytical Development at Forge Biologics, with a focus on nucleic-acid-based quantification of AAV manufacturing residual byproducts. Prior to this, Nick served as a Graduate Research Associate at The Ohio State University, where research centered on brain-directed adeno-associated virus gene therapy for Prader-Willi syndrome, alongside roles as a Research Assistant and Entrepreneurial Lead assessing the market potential of obesity gene therapy. Educational credentials include a PhD in Biomedical Sciences and a BS in Biochemistry, both from The Ohio State University.